Vivimed Labs Gets Export Order worth over Rs 10 crore For Supply Of Generic COVID-19 Drug Favipiravir Ruchika Sharma16 Aug 2020 9:00 AM ISTThe initial Export order Value is worth over INR 100 Million.
Glenmark to introduce stronger version of FabiFlu in India for COVID treatment Ruchika Sharma7 Aug 2020 1:19 PM ISTGlenmark is the first company in India to have received regulator Drug Controller General of India's approval for the 400 mg dosage form, the...
Alkem Labs launches COVID drug favipiravir under brand name Alfluenza in India Ruchika Sharma7 Aug 2020 12:52 PM ISTFavipiravir is approved by the Drug Controller General of India (DCGI) for restricted emergency use.
DCGI nod to Zenara Pharma Favipiravir drug Favizen Ruchika Sharma6 Aug 2020 12:16 PM ISTFavipiravir has demonstrated positive clinical outcomes in some trials and has already been approved for use to treat Covid-19 in Russia and parts of...
Lupin unveils COVID-19 drug under brand name Covihalt for Rs 49 per tablet Ruchika Sharma6 Aug 2020 11:50 AM ISTIt is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs. 49 per tablet.
COVID-19: Sun Pharma launches FluGuard at Rs 35 per tablet in India Ruchika Sharma5 Aug 2020 12:19 PM ISTMumbai: Sun Pharmaceutical Industries Limited. has launched FluGuard® (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the ...
Dr Reddys Labs PAT down by 13 percent to Rs 579.3 crore, gears up to launch 2 COVID drugs next month Ruchika Sharma31 July 2020 12:04 PM ISTThe company has geared up to launch two anti-viral drugs Remdesivir and Favipiravir - for the treatment of COVID-19 next month.
Hetero launches Favipiravir under brand name of Favivir in India, prices it at Rs 59 per tablet Ruchika Sharma30 July 2020 12:33 PM ISTHyderabad: Pharma giant Hetero has announced the launch of generic Favipiravir in India under the brand name 'Favivir.' Hetero has been...
Avra Labs secures CDSCO nod to manufacture, market Favipiravir API Ruchika Sharma28 July 2020 12:11 PM ISTHyderabad: Avra Laboratories Pvt Ltd, a city based pharma company, has been granted regulatory approval by the Central Drugs Standard Control...
Cipla to soon unveil COVID drug Ciplenza for Rs 68 MD Bureau25 July 2020 11:00 AM ISTCipla said it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.
DCGI nod to two cheaper favipiravir versions priced at Rs 59, Rs 39 per tablets Farhat Nasim24 July 2020 4:55 PM ISTBriton Pharma will be marketing Favipiravir under the brand name Faviton in India and will also export it.
Cipla to launch affordable COVID-19 drug Favipiravir Ruchika Sharma24 July 2020 12:50 PM ISTAn off-patent anti-viral drug, Favipiravir, originally discovered by Fuji Pharma in Japan, has shown promise in clinical trials for the treatment of...
